Surgical intelligence platform Theator extends series A with additional $24 million

25 July, 2022

Congratulations to our client Theator on completing an additional $24 million round of funding! This round was led by existing investors Insight Partners with additional investments by Blumberg Capital, StageOne Ventures, NFX, Mayo Clinic, iAngels and other existing shareholders of the company.

Theator’s has developed a surgical intelligence platform to review and analyze surgical procedures, harnessing AI and computer vision to automatically analyze every operation. Theator was represented by attorneys Nimrod Vromen, Josh Hauser and intern Aviva Loboda.

Read full article >>

Want to know more?
Contact us

Shiri Menache

Head of Marketing and Business Development

Matan Bar-Nir

Press Officer, OH! PR